4D Molecular Therapeutics: Executives
Kristian HumerChief Financial OfficerFY2025
Fariborz Kamal, Ph.D.Former Chief Operating Officer & PresidentFY2025
David Kirn, M.D.President and Chief Executive OfficerFY2024
3 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.